A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT07484724 · RECRUITING
Trial details
- NCT number
- NCT07484724
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-13
- Primary completion
- 2027-06-30
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.